ArticleFrontiers in medicine2020

Cilomilast Ameliorates Renal Tubulointerstitial Fibrosis by Inhibiting the TGF-β1-Smad2/3 Signaling Pathway.

Man Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.